SCHEMBL1503083

SCHEMBL1503083

COc1ccc(CNC(=O)c2ccc(C(N)=O)cn2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.64
L3MBTL1 Q9Y468 2/20 0.64
CYP1A2 P05177 2/20 0.64
POLB P06746 2/20 0.64
CYP3A4 P08684 2/20 0.64
CYP2C9 P11712 2/20 0.64
CYP2C19 P33261 2/20 0.64
HPGD P15428 1/20 0.64
ATM Q13315 1/20 0.64
RAB9A P51151 4/20 0.60
VNN1 O95497 3/20 0.60
NPC1 O15118 3/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
EPHX2 P34913 1/20 0.54
NR1H4 Q96RI1 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
BCHE P06276 1/20 0.53
ACHE P22303 1/20 0.53
MMP13 P45452 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13210601 0.91 ALDH1A1 (0.68) ALDH1A1L3MBTL1CYP1A2POLBCYP3A4
SCHEMBL15331434 0.80 ALDH1A1 (0.64) ALDH1A1L3MBTL1CYP1A2POLBCYP3A4
SCHEMBL3098294 0.80 MEN1 (0.77) ALDH1A1L3MBTL1CYP1A2POLBCYP3A4
SCHEMBL30465779 0.80 VNN1 (0.70) RAB9AVNN1NPC1KMT2AHDAC1
SCHEMBL15259162 0.78 EPHX2 (0.45) L3MBTL1EPHX2NR1H4SMN1; SMN2HDAC1
SCHEMBL9416606 0.78 NPC1 (0.82) ALDH1A1L3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL11761142 0.78 NPC1 (0.82) ALDH1A1L3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL8868113 0.77 P4HTM (0.67) ALDH1A1L3MBTL1CYP1A2POLBCYP3A4
SCHEMBL3688883 0.77 OPRM1 (0.80) VNN1
SCHEMBL27962856 0.76 RAB9A (0.70) ALDH1A1L3MBTL1CYP1A2POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300433-A1 HIV INTEGRASE INHIBITORS FROM PYRIDOXINE Ambrilia Biopharma Inc. (CA) 2011-03-30 EP disclosed